ライフサイエンスコーパス: blood pressure control

1 rations in microbial communities relevant in blood pressure control.

2 gic system in salt and water homeostasis and blood pressure control.

3 These factors are associated with poor blood pressure control.

4 i-ischemic therapy, and aggressive lipid and blood pressure control.

5 l ENaC is critical for Na(+) homeostasis and blood pressure control.

6 nal C1 adrenergic neurons and is involved in blood pressure control.

7 echanism by which patient education improved blood pressure control.

8 ivate patients to achieve strict glucose and blood pressure control.

9 uation of the hypertensive patient with poor blood pressure control.

10 dication when evaluating a patient with poor blood pressure control.

11 are had room for improvement, especially for blood pressure control.

12 sport, contributing to Na(+) homeostasis and blood pressure control.

13 tment with more than 1 drug class to achieve blood pressure control.

14 overt CHF who are candidates for aggressive blood pressure control.

15 effective as enalapril in LVH regression and blood pressure control.

16 fering is an important mechanism in arterial blood pressure control.

17 ose associated with conventional therapy and blood pressure control.

18 plays a critical role in Na+ homeostasis and blood pressure control.

19 nd tubular function that, in turn, influence blood pressure control.

20 n-angiotensin system, a major participant in blood pressure control.

21 ve treatment still remain on medications for blood pressure control.

22 d felodipine, a calcium channel blocker, for blood pressure control.

23 s also received furosemide concomitantly for blood pressure control.

24 or insulin resistance, lipid metabolism, and blood pressure control.

25 ent reviews for people with poor glycemic or blood pressure control.

26 f adherence to antihypertensive treatment on blood pressure control.

27 can prevent glucose intolerance and improve blood pressure control.

28 equired for physiological vasoreactivity and blood pressure control.

29 nal inflammation and fibrosis independent of blood pressure control.

30 eration, angiogenesis, channel activity, and blood pressure control.

31 benefit from late CNI withdrawal by improved blood pressure control.

32 e to osmotic stress is important to systemic blood pressure control.

33 sels and is considered a major mechanism for blood pressure control.

34 (ENaC) is critical for Na(+) homeostasis and blood pressure control.

35 LV diastolic function and facilitated better blood pressure control.

36 ignificantly differ between strict and usual blood pressure control.

37 bitors and beta-blockers, and low for strict blood pressure control.

38 ial Na(+) absorption, a major contributor to blood pressure control.

39 ing bilateral adrenalectomy in childhood for blood pressure control.

40 ertensives may facilitate efforts to improve blood pressure control.

41 Renin is essential for blood pressure control.

42 ease to receive either intensive or standard blood-pressure control.

43 her risk of coronary events, despite similar blood-pressure control.

44 with antihypertensive medications have their blood pressure controlled.

45 e and 60% of treated hypertensive people had blood pressure controlled.

46 uestion in hypertension is: How is long-term blood pressure controlled?

47 (1.26, 1.08-1.47; p=0.0038), and have their blood pressure controlled (1.13, 1.00-1.28; p=0.0562) th

48 ed to the patient education group had better blood pressure control (138/75 mm Hg) than those in the

49 treated male hypertensive patients with good blood pressure control (139.6/85.7 mm Hg), young blacks,

50 y (1.53, 1.13-2.07; p=0.054), and have their blood pressure controlled (2.06, 1.69-2.50; p<0.0001) th

51 Individually, blood pressure control (57.9%) had the lowest overall at

52 The mechanism(s) underlying blood pressure control across the menstrual cycle in wom

53 s), weight loss (adding 1.6 life-years), and blood pressure control (adding 0.8 life-year).

54 ith HF-preserved EF less frequently achieved blood pressure control (adjusted odds ratio, 0.44 versus

55 Blood pressure control, along with delivery, will be the

56 pertension were aware of the diagnosis, with blood pressure control among 32.5% of those being treate

57 ypertensive medication use and its impact on blood pressure control among US adults with hypertension

58 Antihypertensive medication use and blood pressure control among US adults with hypertension

59 ed renal function had a beneficial effect on blood pressure control and a nondeleterious effect on re

60 a post hoc analysis of the Effect of Strict Blood Pressure Control and ACE Inhibition on Progression

61 medical therapy as a factor leading to poor blood pressure control and adverse outcomes remains a ke

62 Furthermore, myeloid MR is critical for blood pressure control and for hypertrophic and fibrotic

63 rect targets and mechanisms linking FGF21 to blood pressure control and hypertension are still elusiv

64 udy identifies a new role for vascular MR in blood pressure control and in vascular aging and support

65 t protocols including intensive glycemic and blood pressure control and laser photocoagulation for ne

66 ions, in addition to meticulous attention to blood pressure control and lifestyle changes, have the p

67 egarding the importance of blood glucose and blood pressure control and may motivate patients to achi

68 The C1 neurons are a nodal point for blood pressure control and other autonomic responses.

69 stained-release- or atenolol-based strategy; blood pressure control and outcomes were equivalent.

70 describe the role of pressure natriuresis in blood pressure control and outline the cascade of biophy

71 a complex but important factor in achieving blood pressure control and reducing adverse cardiovascul

72 procedures sometimes offer major benefits in blood pressure control and stabilization of renal functi

73 tional basis for the effects of estrogens on blood pressure control and suggest a mechanism for the m

74 LA dilatation may be mediated by blood pressure control and the development of visceral a

75 ion to improve both medication adherence and blood pressure control and to reduce cardiovascular even

76 rtensive patients need two or more drugs for blood-pressure control and concomitant statin treatment

77 terol control, 1 in 3 persons still has poor blood pressure control, and 1 in 5 persons still has poo

78 entive measures including smoking cessation, blood pressure control, and lipid management.

79 inhibitors and ARBs have similar effects on blood pressure control, and that ACE inhibitors have hig

80 ange between the proportion of patients with blood pressure control/appropriate response for individu

81 directed toward earlier and more aggressive blood pressure control are likely to offer the greatest

82 Strategies used system-wide included blood pressure control as a performance measure, automat

83 e hoping that it would translate into better blood pressure control as well as incremental nephroprot

84 The primary outcome was blood pressure control at 6 months.

85 We measured blood pressure control at the index visit, overall good

86 xide release, whereas for the same degree of blood pressure control, atenolol/bendrofluazide had no e

87 heral vascular disease associated with tight blood-pressure control became significant (P=0.02).

88 nts receiving antihypertensive therapy (with blood pressure controlled below target levels) had reduc

89 additional meaningful barriers to achieving blood pressure control beyond access to the monitor itse

90 he association between adherence and TI with blood pressure control (BP </= 140/90 at the clinic visi

91 ccurred in diagnosis, treatment and adequate blood pressure control (BP below 140/90 mmHg) since 2001

92 as effective in improving both adherence and blood pressure control, but it did not appear to improve

93 tics that could inform strategies to improve blood pressure control by decreasing untreated hypertens

94 tihypertensive drug utilization patterns and blood pressure control by insurance status, age, sex, an

95 ic hypertension (after an initial attempt at blood pressure control by weight reduction, if indicated

96 High rates of blood pressure control can be achieved in all age and et

97 tegration of vestibular system pathways with blood pressure control centers in the ventrolateral medu

98 for aspirin or antithrombotic prescription, blood pressure control, cholesterol control, and smoking

99 S" (aspirin therapy in appropriate patients, blood pressure control, cholesterol management, and smok

100 scular disease, including lifestyle factors, blood pressure control, cholesterol-lowering, antithromb

101 vention including patient education improved blood pressure control compared with provider education

102 sure, we found a small reduction in systolic blood pressure control compared with usual care at 12 mo

103 y controlled hypertension resulted in better blood pressure control compared with usual care.

104 t the importance of dietary sodium intake in blood pressure control, consideration of the most recent

105 sk factors for bleeding should be addressed (blood pressure control, discontinuing unnecessary medica

106 tarling mechanism contributes to compromised blood pressure control during simulated haemorrhage in h

107 r disease, achieved with the use of improved blood-pressure control during the trial, would be sustai

108 ion, skeletal muscle pump was found to drive blood pressure control (EMG --> SBP) as well as control

109 Blood pressure control, especially with medications that

110 of intraventricular hemorrhage, and adequate blood pressure control for the optimization of cerebral

111 ngs for redefinition of future management of blood-pressure control for individuals at high risk of s

112 l lateral PBN (LPBN) relative to surgery and blood pressure control groups.

113 In overall analyses, intensive blood-pressure control had no effect on kidney disease p

114 Patients randomized to placebo (moderate blood pressure control) had a mean blood pressure of 137

115 Intensive glycemic and blood pressure control has been shown to delay both the

116 An essential link between the kidney and blood pressure control has long been known.

117 Strategies to improve blood pressure control have been implemented in the Unit

118 Blood pressure control improved significantly more in ab

119 t of this clinical problem, and they achieve blood pressure control in 65% of patients.

120 surgery represents an effective strategy for blood pressure control in a broad population of patients

121 on the contextual red flag, such as improved blood pressure control in a patient presenting with hype

122 there are cardiovascular benefits other than blood pressure control in blocking the renin system rema

123 association with use of these medicines and blood pressure control in countries at varying levels of

124 The Appropriate Blood Pressure Control in Diabetes (ABCD) Trial is a pro

125 The Appropriate Blood Pressure Control in Diabetes study followed 950 su

126 ports its role as a polygenic determinant of blood pressure control in humans, and results obtained f

127 important opportunity for further improving blood pressure control in our society.

128 f ischemic events, but the role of intensive blood pressure control in PAD has not been established.

129 ed statistically significant improvements in blood pressure control in patients with diabetes balance

130 [95% CI, 5.2 to 26.3 percentage points]) and blood pressure control in patients with hypertension (im

131 eplerenone and spironolactone, in improving blood pressure control in patients with resistant hypert

132 ommendations issued by scientific societies, blood pressure control in RTRs is far from the recommend

133 ch is believed to play an important role for blood pressure control in the adult.

134 p; the time-to-event experience of achieving blood pressure control in the intervention versus contro

135 s for regulation of catecholamine action and blood pressure control in this widely studied model of h

136 GI-alpha oxidation in the EDHF mechanism and blood pressure control in vivo, we generated a knock-in

137 regulatory systems that are associated with blood pressure control in women.

138 ther vasopressors may contribute to improved blood-pressure control in CAPD in contrast to hemodialys

139 ms of Na-K-ATPase inhibitors might relate to blood-pressure control in hemodialysis (N = six ultrafil

140 findings emphasise the importance of prompt blood-pressure control in hypertensive patients at high

141 py with an ACE inhibitor was associated with blood-pressure control in most patients with ADPKD and s

142 ere may be differential effects of intensive blood-pressure control in patients with and those withou

143 Early improvement in blood-pressure control in patients with both type 2 diab

144 adherence and TI, the odds (OR) of achieving blood pressure control increased by 28% and 55%, respect

145 Inadequate blood pressure control is a persistent gap in quality ca

146 Continued blood pressure control is necessary to maintain benefici

147 A key factor contributing to poor blood pressure control is suboptimal adherence to prescr

148 assist device support yet their relation to blood pressure control is underexplored.

149 s, angiotensin-converting enzyme inhibitors, blood pressure control, lipid control, diabetic glycemic

150 Blood pressure control, lipid-lowering therapy, angioten

151 ntemporary approach of antiplatelet therapy, blood pressure control, low-density lipoprotein reductio

152 in cholesterol <70 mg/dL or statin therapy), blood pressure control (<140 mm Hg systolic, <90 mm Hg d

153 se) of implantable intracardiac devices, and blood pressure control (<140/90 mm Hg).

154 cemic control, avoidance of smoking and good blood pressure control may be helpful in preventing or d

155 Particularly in black women, weight and blood pressure control may be important community health

156 Aggressive blood pressure control may be the most important factor

157 ntrol, smoking cessation and prevention, and blood pressure control may help to reduce the risk of ha

158 12 patients with stage 2 and 3 CKD with good blood pressure control (mean daytime ambulatory blood pr

159 CPAP or no therapy while maintaining usual blood pressure control medication.

160 k of complications, but it appears that good blood-pressure control must be continued if the benefits

161 to prevent the development of HF, especially blood pressure control, must be a priority if mortality

162 2% to 9.7%], P = .001 for interaction term), blood pressure control (no comorbidities: 9.7% vs 4.3%,

163 e effect of the procedure on renal function, blood pressure control, number of antihypertensive medic

164 ifferences between fatty acid metabolism and blood pressure control of humans and laboratory animals,

165 Patients with adequate blood pressure control on captopril, hydrochlorothiazide

166 Blood pressure control optimization is immediate and per

167 or combined incentives, resulted in greater blood pressure control or appropriate response to uncont

168 A) and stenting indicate that improvement in blood pressure control or renal function is not a predic

169 ess than 9.0% (OR, 0.96 [95% CI, 0.74-1.2]); blood pressure control (OR, 0.99 [95% CI, 0.69-1.4]); LD

170 iated with a 25% increased odds of achieving blood pressure control (OR, 1.24; 95% CI, 1.21-1.27).

171 y of DN resulting from improved glycemia and blood pressure control, or whether there were overestima

172 study was designed to assess improvement in blood pressure control over a 10-year period in a large

173 ight loss, smoking cessation, and aggressive blood pressure control, particularly in African-American

174 renal dysfunction could beneficially affect blood pressure control, preserve or prevent deterioratio

175 In this simulation study, intensive systolic blood-pressure control prevented cardiovascular disease

176 Blood pressure control rates improved from 45.7% in Sept

177 nts with hypertension to tight or less-tight blood-pressure control regimens.

178 ed with 55% and 26% increased likelihoods of blood pressure control, respectively.

179 Yet few trials have tested whether intensive blood-pressure control retards the progression of chroni

180 lic acidosis and anemia, achieving excellent blood pressure control, reversing cardiovascular complic

181 As compared with standard blood-pressure control, rigorous blood-pressure control

182 ts, Mr R faces several barriers to effective blood pressure control: societal, health system, individ

183 ed established lifestyle recommendations for blood pressure control (sodium reduction, weight loss, a

184 There is a pressing need for blood pressure-control strategies with improved efficacy

185 mphocytes in peripheral tissues important in blood pressure control, such as the kidney and vasculatu

186 wide-association studies broaden our view of blood pressure control, suggesting that renal sympatheti

187 Reaching blood pressure control (systolic <140 mm Hg) by 6 months

188 ular disease who received intensive systolic blood-pressure control (target, <120 mm Hg) had signific

189 iometabolic events and death, independent of blood pressure control, than for patients with essential

190 Thus, with intensive blood pressure control, the risk of an event was not inc

191 Of neural sites participating in blood pressure control, the rostral ventrolateral medull

192 In addition to blood pressure control, therapies targeting load-indepen

193 ial cells, consistent with a primary role in blood pressure control through modulation of vascular to

194 factor for stroke, a national guideline for blood-pressure control to reduce the incidence of stroke

195 tatistically significant, ranging from 0.01 (blood pressure control) to -0.21 (cholesterol control in

196 Patient outcomes (glycemic, cholesterol, and blood pressure control, urgent care visits, emergency de

197 ned to test the hypothesis that for the same blood-pressure control, valsartan would reduce cardiac m

198 Blood pressure control was higher in both age groups wit

199 to 80+/-11 mm Hg, respectively; P<0.05), and blood pressure control was more facile in approximately

200 Blood pressure control was poor in both groups (52% to 5

201 Two-year blood pressure control was similar between groups.

202 th standard blood-pressure control, rigorous blood-pressure control was associated with a slower incr

203 To test this hypothesis and its relevance to blood pressure control, we determined whether RGS2 funct

204 enin ratio (ARR), serum potassium level, and blood pressure control were assessed at 3 months and at

205 Significant positive predictors of adequate blood pressure control were CHD and antihypertensive med

206 vascular mortality and results for intensive blood pressure control were inconsistent.

207 eceiving tight, as compared with less tight, blood-pressure control were not sustained during the pos

208 The benefits of previously improved blood-pressure control were not sustained when between-g

209 affordability to use of these medicines and blood pressure control with multilevel mixed-effects log

210 of patients still do not achieve recommended blood pressure control worldwide.